In fact, genes such as Axin2 and miR-195-5p are multi-target in colon cancer, and the overexpression/manipulation of them may affect the expression of other genes, thus resulting in the expression of beta-catenin inconsistent with the common regulatory relationship. This evidence concerns the gene AXIN2 and colonic neoplasm.